IL-17 derived from juxta-articular bone and synovium contributes to joint degradation in rheumatoid arthritis

Citations Over TimeTop 1% of 2001 papers

Abstract

The origin and role of IL-17, a T-cell derived cytokine, in cartilage and bone destruction during rheumatoid arthritis (RA) remain to be clarified. In human ex vivo models, addition of IL-17 enhanced IL-6 production and collagen destruction, and inhibited collagen synthesis by RA synovium explants. On mouse cartilage, IL-17 enhanced cartilage proteoglycan loss and inhibited its synthesis. On human RA bone explants, IL-17 also increased bone resorption and decreased formation. Addition of IL-1 in these conditions increased the effect of IL-17. Blocking of bone-derived endogenous IL-17 with specific inhibitors resulted in a protective inhibition of bone destruction. Conversely, intra-articular administration of IL-17 into a normal mouse joint induced cartilage degradation. In conclusion, the contribution of IL-17 derived from synovium and bone marrow T cells to joint destruction suggests the control of IL-17 for the treatment of RA.

Related Papers

• The effect of human interleukin 1 on proteoglycan metabolism in human and porcine cartilage explants.(1990)
• Local changes in proteoglycan synthesis during culture are different for normal and osteoarthritic cartilage.(1992)
• → Studies on the mechanism of cartilage degradation(1984)25 cited
• → Presence of link protein in cartilage from cmd/cmd (cartilage matrix deficiency) mice(1983)8 cited
• Proteoglycans from experimental osteoarthritic cartilage: degradation by neutral metalloproteases.(1987)